Skip to main content
See every side of every news story
Published loading...Updated

Scientists are working on a hantavirus vaccine — but it’s likely years away

Scientists say the virus’s sporadic outbreaks and limited commercial incentive have kept most candidates in preclinical testing for years.

The hantavirus outbreak on the MV Hondius cruise ship brings a new focus to efforts to develop a vaccine to prevent the virus. Experts say hantavirus vaccine efforts have repeatedly stalled, in part because outbreaks tend to occur sporadically and disproportionately affect poorer countries where there is less incentive for drugmakers to invest. “Our funding agencies don’t put a lot of money into this, because it’s likely not to cause the next ep…

9 Articles

Lean Right

The explosion of interest on the internet by the modern vaccine and the hantavirus has turbineized the roles of pharmaceuticals, which have already risen almost 16% since the WHO reported the cases of the ship MV Hondius

·Brazil
Read Full Article

The multinational outbreak of hantavirus associated with the cruise ship MV Hondius has triggered global alarms, and one of the most well-known specialties to address this health scenario is Immunology. Currently there is no authorised vaccine against hantavirus in Europe, the United States or Latin America, although the Spanish Society of Immunology (SEI) warns that “there are active lines of research against the Andes virus, the only one with …

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources lean Right
50% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Scientific American broke the news on Friday, May 8, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal